We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.29B
AUM Growth
-$11.6M
Cap. Flow
-$21.9M
Cap. Flow %
-1.71%
Top 10 Hldgs %
35.16%
Holding
270
New
6
Increased
38
Reduced
92
Closed
7

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.2M
2
BP icon
BP
BP
+$4.27M
3
MRK icon
Merck
MRK
+$2.01M
4
UNP icon
Union Pacific
UNP
+$1.24M
5
ON icon
ON Semiconductor
ON
+$1.02M

Sector Composition

Rank Sector Weight
1 Technology 21%
2 Healthcare 18.86%
3 Financials 15.21%
4 Industrials 11.46%
5 Communication Services 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTE icon
226
DTE Energy
DTE
$28.5B
-3,290
Closed -$363K
RPM icon
227
RPM International
RPM
$14.8B
-2,416
Closed -$214K
VTRS icon
228
Viatris
VTRS
$18.7B
-10,054
Closed -$144K
XBI icon
229
State Street SPDR S&P Biotech ETF
XBI
$10.4B
-3,830
Closed -$519K
WHWK
230
Whitehawk Therapeutics
WHWK
$259M
-6,667
Closed -$169K

Similar funds

Neville Rodie & Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, Neville Rodie & Shaw held 270 positions worth $1.29B, down 0.89% from $1.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.8%. Neville Rodie & Shaw opened 6 new positions and exited 7, leaving the 270-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q3 2021 buy was Block Inc: 2,460 shares worth $590K.
  • Neville Rodie & Shaw added most to Accenture in Q3 2021, an estimated $390K increase.
  • Neville Rodie & Shaw's biggest Q3 2021 reduction was ExxonMobil, cutting an estimated $5.2M.
  • Neville Rodie & Shaw fully exited State Street SPDR S&P Biotech ETF in Q3 2021, selling an estimated $519K.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.29B portfolio in Q3 2021.
  • Neville Rodie & Shaw opened 6 new positions and closed 7 in Q3 2021.
  • Neville Rodie & Shaw's portfolio value fell 0.89% quarter-over-quarter to $1.29B.

Based on Neville Rodie & Shaw's 13F filing for Q3 2021, filed 6 Oct 2021.